People: Rico Auto Industries Ltd (RAUT.NS)

RAUT.NS on National Stock Exchange of India

9:29am IST
Change (% chg)

Rs-0.10 (-0.15%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Seth, Ashok 

Dr. Ashok Seth is the Non-Executive Independent Director of Rico Auto Industries Limited., He was appointed as Director by the Board of Directors on 13th May, 2004 is FRCP (London, Edinburg, Ireland), FACC, FSCAI (USA), FIMSA, D.Sc. (Honoris Causa), D.Litt (Honoris Causa). He is Chairman of Escorts Heart Institute and Research Centre Limited, New Delhi, India. Earlier he was Chairman of the Max Heart & Vascular Institute, New Delhi, India and on the Board of Directors of Max Healthcare. He is the Immediate Past President of Cardiological Society of India, the Vice President of Asia Pacific Society of Cardiology and also on the Board and Founder Governor of numerous international societies. He is a member of several prestigious international scientific bodies. He is an honorary faculty to various medical colleges in India and Overseas. He has been invited extensively to lecture and teach in numerous international meetings across the World. He is also the Board of Trustees of Society for Cardiovascular Angiography and Interventions (SCAI), USA. He has received numerous awards from National and International Forum, several Lifetime Achievement Awards and also been honoured by the National Award of Spain “Crus De Oficial Con Insignia Orden De Isabel La Catolica”. He is Founder Governor and Honorary Secretary of the Endovascular Intervention Society of India & is Governor/Advisory Boards and Executive Committees of numerous important International Organizations such as the Asia Pacific Society of Interventional Cardiology, SAARC Cardiac Society and Indo-French Cardiovascular Foundation and Academy of TCT, Washington USA. He is also on Editorial Boards of numerous International Scientific Journals. He is Advisor to ICMR on Task force of developing indigenous Cardiovascular implants. He is also the Member of the Monitoring Committee of CSIR for “Novel Method for Development of B-Type Natriuretic Peptode (BNP) for the diagnosis and treatment of Congestive Heart Failure”.

Basic Compensation

Total Annual Compensation, INR 136,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 136,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Arvind Kapur


B. Jhamb


Arun Kapur


G. Bisht


R. Dharna


M. Jain

As Of  31 Mar 2014